INVESTOR-SC25I20402EB26249
$495.00
Purchase for full contact information of one or more deal team members. All purchases are final and non-refundable.
Description
PE Fund
Focused on the following industries:
– Healthcare
– Pharma Services
– Payor Services
– Tech-Enabled
– HC or Life Sciences Consulting
– Medical Education and Training
– Outsourced Services
– Behavioral Health
– Dental Specialties
– ENT
– Womens Health
– Specialty Veterinary Services
– Post-Acute
– Contract Manufacturing
– Specialty Pharmacy & Compounding
– Medical Products
Target Company Characteristics:
– Headquartered in the United States or Canada
– Founder-owned, entrepreneurially-led
– Strong business model, with a history of consistent growth and profitability
– Positive secular growth trends and resilient end market
– Fragmented market landscape
– Strong demand, implying good revenue visibility (recurring or re-occurring)
– Limited regulatory risk
Transaction Types:
– Control positions in healthcare software and technology businesses
– Partial recapitalizations or buyouts
Company Size:
– EBITDA $5-$25M
Target equity investments
– $30-$150M
– Target add-on investments
– Cash Flow Positive